PXi multi-application imager used for new fluorescent peptide imaging application

Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce its PXi multi-application imager is being used by scientists at the prestigious Freie Universtät Berlin for the new application of imaging fluorescent peptides on Western blots. Using the system is providing the researchers with a simple, sensitive method to detect cancer-linked transcription factors.

In the Institute for Pharmacy at the Freie Universtät Berlin in Germany, scientists are using the PXi imaging system fitted with a 4 million pixel CCD camera, for imaging a peptide labelled with 5-carboxyfluorescein to fish out key interacting protein partners to essential transcription factors on Western blots. This drug discovery research may contribute to finding druggable targets for treating leukemia and other life threatening cancers.

Ee Lin Wong, a Ph.D. student in the Department of Pharmacy explained:

We work with a fluorescent peptide on Western blots but we can’t image our results using X-ray film because the fluorescence with this peptide can get so bright that it causes band saturation which over-exposes the film and ruins the results. Then we must start all over again with new film, which takes time and is frustrating.

Ee Lin added:

We chose the PXi because the system is compact, yet is more sensitive than film. This saves time as we can detect the proteins we’re looking for without having to keep repeating our fluorescent blots or use extra X-ray film. The best thing about the PXi is that the software is very fast and downloads images we can save to a USB stick in a format we can easily analyze and transfer into a file at exactly the right specifications for publication. This allows us to submit good quality figures more rapidly to scientific journals and is a great feature of the PXi system.

To find out more about the fluorescence imaging capabilities of the multi-functional PXi system, please click here: http://www.syngene.com/pxi-pxi-touch

“We’re always pleased to hear about new and exciting applications of our imaging technology,” stated Dr Martin Biggs, Sales Manager at Syngene.

“The research at this prestigious German institute shows that the PXi imaging system is an excellent choice for drug discovery scientists looking to access sensitive detection of fluorescent peptides, as well as quickly and easily generate publication-quality formats of their important scientific data.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Syngene. (2019, June 19). PXi multi-application imager used for new fluorescent peptide imaging application. News-Medical. Retrieved on October 12, 2024 from https://www.news-medical.net/news/20170908/PXi-multi-application-imager-used-for-new-fluorescent-peptide-imaging-application.aspx.

  • MLA

    Syngene. "PXi multi-application imager used for new fluorescent peptide imaging application". News-Medical. 12 October 2024. <https://www.news-medical.net/news/20170908/PXi-multi-application-imager-used-for-new-fluorescent-peptide-imaging-application.aspx>.

  • Chicago

    Syngene. "PXi multi-application imager used for new fluorescent peptide imaging application". News-Medical. https://www.news-medical.net/news/20170908/PXi-multi-application-imager-used-for-new-fluorescent-peptide-imaging-application.aspx. (accessed October 12, 2024).

  • Harvard

    Syngene. 2019. PXi multi-application imager used for new fluorescent peptide imaging application. News-Medical, viewed 12 October 2024, https://www.news-medical.net/news/20170908/PXi-multi-application-imager-used-for-new-fluorescent-peptide-imaging-application.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Syngene’s next generation GeneSys image capture software offers picture perfect chemi blot images